|
|
||||||||
1 Department of Pharmacology and 3 Research Equipment Center, Kagawa Medical University, Kagawa 761-0793; and 2 Department of Pharmacology, Osaka City University Medical School, Osaka 545-8585, Japan
The present study was conducted to determine the metabolism of renal interstitial adenosine under resting conditions and during ischemia. By using a microdialysis method with HPLC-fluorometric analysis, renal interstitial concentrations of adenosine, inosine, and hypoxanthine were assessed in pentobarbital-anesthetized dogs. Average basal renal interstitial concentrations of adenosine, inosine, and hypoxanthine were 0.18 ± 0.04, 0.31 ± 0.05, and 0.35 ± 0.05 µmol/l, respectively. Local inhibition of adenosine kinase with iodotubercidin (10 µmol/l in perfusate) or inhibition of adenosine deaminase with erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA; 100 µmol/l in perfusate) did not change adenosine concentrations in the nonischemic kidneys (0.18 ± 0.04 and 0.24 ± 0.05 µmol/l, respectively). On the other hand, treatment with iodotubercidin+EHNA significantly increased adenosine concentration (0.52 ± 0.07 µmol/l) with significant decreases in inosine and hypoxanthine levels (0.13 ± 0.03 and 0.19 ± 0.04 µmol/l, respectively). During 30 min of ischemia, adenosine, inosine, and hypoxanthine were significantly increased to 0.76 ± 0.29, 2.14 ± 0.45, and 21.8 ± 4.7 µmol/l, respectively. The treatment with iodotubercidin did not alter ischemia-induced increase in adenosine (0.84 ± 0.18 µmol/l); however, EHNA alone markedly enhanced adenosine accumulation (13.54 ± 2.16 µmol/l), the value of which was not augmented by an addition of iodotubercidin (15.80 ± 1.24 µmol/l). In contrast, ischemia-induced increases in inosine and hypoxanthine were inversely diminished by the treatment with iodotubercidin+EHNA (0.90 ± 0.20 and 9.86 ± 1.96 µmol/l, respectively). These results suggest that both adenosine kinase and adenosine deaminase contribute to the metabolism of renal interstitial adenosine under resting conditions, whereas adenosine produced during ischemia is mainly metabolized by adenosine deaminase and the rephosphorylation of adenosine by adenosine kinase is small.
renal interstitium; adenosine deaminase; adenosine kinase
This article has been cited by other articles:
![]() |
M. Franco, R. Bautista, O. Perez-Mendez, L. Gonzalez, U. Pacheco, L. G. Sanchez-Lozada, J. Santamaria, E. Tapia, R. Monreal, and F. Martinez Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats Am J Physiol Renal Physiol, January 1, 2008; 294(1): F84 - F92. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Hansen and J. Schnermann Vasoconstrictor and vasodilator effects of adenosine in the kidney Am J Physiol Renal Physiol, October 1, 2003; 285(4): F590 - F599. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Aki, A. Nishiyama, A. Miyatake, S. Kimura, M. Kohno, and Y. Abe Role of Adenosine A1 Receptor in Angiotensin II- and Norepinephrine-Induced Renal Vasoconstriction J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 117 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nishiyama, D. M. Seth, and L. G. Navar Renal Interstitial Fluid Concentrations of Angiotensins I and II in Anesthetized Rats Hypertension, January 1, 2002; 39(1): 129 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-F. Chen, P.-L. Li, and A.-P. Zou Oxidative stress enhances the production and actions of adenosine in the kidney Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1808 - R1816. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |